BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 10953920)

  • 1. The growth inhibition of hepatoma by gene transfer of antisense vascular endothelial growth factor.
    Kang MA; Kim KY; Seol JY; Kim KC; Nam MJ
    J Gene Med; 2000; 2(4):289-96. PubMed ID: 10953920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
    Saleh M; Stacker SA; Wilks AF
    Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts.
    Oku T; Tjuvajev JG; Miyagawa T; Sasajima T; Joshi A; Joshi R; Finn R; Claffey KP; Blasberg RG
    Cancer Res; 1998 Sep; 58(18):4185-92. PubMed ID: 9751633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
    Goto F; Goto K; Weindel K; Folkman J
    Lab Invest; 1993 Nov; 69(5):508-17. PubMed ID: 8246443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production.
    Zeng G; Gao L; Birklé S; Yu RK
    Cancer Res; 2000 Dec; 60(23):6670-6. PubMed ID: 11118051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of K562 cell growth and tumor angiogenesis in nude mice by antisense VEGF(121) cDNA transfection].
    Ruan G; Liu Y; Chen S; Qin Y; Li J; Fu J; Yu H; Chang Y
    Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):179-82. PubMed ID: 12133452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo.
    Im SA; Gomez-Manzano C; Fueyo J; Liu TJ; Ke LD; Kim JS; Lee HY; Steck PA; Kyritsis AP; Yung WK
    Cancer Res; 1999 Feb; 59(4):895-900. PubMed ID: 10029081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector.
    Byun J; Heard JM; Huh JE; Park SJ; Jung EA; Jeong JO; Gwon HC; Kim DK
    J Mol Cell Cardiol; 2001 Feb; 33(2):295-305. PubMed ID: 11162134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.
    Claffey KP; Brown LF; del Aguila LF; Tognazzi K; Yeo KT; Manseau EJ; Dvorak HF
    Cancer Res; 1996 Jan; 56(1):172-81. PubMed ID: 8548760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.
    Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A
    Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic angiogenesis using genetic transfection. An in vitro quantitative and functional study after gene code transfer for vascular endothelial growth factor].
    Zaric V; Weltin D; Stephan D
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):987-91. PubMed ID: 10989743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
    Takayama K; Ueno H; Nakanishi Y; Sakamoto T; Inoue K; Shimizu K; Oohashi H; Hara N
    Cancer Res; 2000 Apr; 60(8):2169-77. PubMed ID: 10786681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor.
    Gerber HP; Kowalski J; Sherman D; Eberhard DA; Ferrara N
    Cancer Res; 2000 Nov; 60(22):6253-8. PubMed ID: 11103779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
    Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
    Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis.
    Yano S; Shinohara H; Herbst RS; Kuniyasu H; Bucana CD; Ellis LM; Davis DW; McConkey DJ; Fidler IJ
    Cancer Res; 2000 Sep; 60(17):4959-67. PubMed ID: 10987313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase--implications for gene therapy in cardiovascular diseases.
    Dulak J; Józkowicz A; Guevara I; Dembińska-Kieć A
    Pol J Pharmacol; 1999; 51(3):233-41. PubMed ID: 10600037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells.
    Yoshiji H; Kuriyama S; Yoshii J; Yamazaki M; Kikukawa M; Tsujinoue H; Nakatani T; Fukui H
    Hepatology; 1998 Dec; 28(6):1489-96. PubMed ID: 9828211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.
    Davidoff AM; Nathwani AC; Spurbeck WW; Ng CY; Zhou J; Vanin EF
    Cancer Res; 2002 Jun; 62(11):3077-83. PubMed ID: 12036917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.